The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Advancement Program, 2016Upregulation of Autophagy by Tet3-mediated 5-methylcytosine oxidation – Relevance to Parkinson's Disease
Study Rationale:
An abnormally folded version of the protein alpha-synuclein forms characteristic clumps (Lewy bodies) in nerve cells in Parkinson's disease (PD). One possible reason for this is an... -
Target Advancement Program, 2016Role of PINK1 and Parkin in Innate Immunity: Crosstalk between Mitochondrial Dysfunction and NLRP3 Inflammasome Signaling
Study Rationale:
Mitochondrial dysfunction and neuroinflammation play major roles in Parkinson's disease (PD). Overactivation of the inflammasome (innate immune system receptor) signaling complex NLRP3... -
Target Advancement Program, 2016Evaluation of PARIS (ZNF746) as a Target of Alpha-synuclein Toxicity in Parkinson's Disease and Alpha-synucleinopathies
Study Rationale:
We have recently identified Parkin-Interacting Substrate (PARIS), a Kruppel associated box (KRAB) and zinc finger protein, as a substrate of the parkin, E3 ubiquitin ligase. PARIS... -
Target Advancement Program, 2016Targeting Novel Transcriptional Pathways to Reduce Alpha-synuclein Expression
Study Rationale:
Many scientific studies have shown that one of the major causes of Parkinson's disease (PD) is the accumulation of a protein named alpha-synuclein in a certain type of neurons. When... -
Target Advancement Program, 2016Investigating the Effect of Parkin on Alpha-synuclein Propagation
Study Rationale:
Parkinson's disease (PD) has been demonstrated to start within the olfactory bulb (brain region that processes smell) and brain stem (brain region that controls involuntary functions)... -
Target Advancement Program, 2016Structural Insights into Activated Intermediates of Parkin
Study Rationale:
Failure in the quality control of mitochondria (power houses of the cell) in neurons may contribute to Parkinson's disease (PD). Parkin is an enzyme that tags proteins from damaged...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.